NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through FAS/CD95 Inhibition.
Endocrinology
; 165(2)2023 Dec 23.
Article
in En
| MEDLINE
| ID: mdl-38091978
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Thyroid Carcinoma, Anaplastic
Limits:
Humans
Language:
En
Journal:
Endocrinology
Year:
2023
Document type:
Article
Affiliation country:
Italy